The Clinical Trials Centre is made up of clinical staff at St Mary’s Hospital and laboratory, operational and management staff at Imperial College London. The clinical team have close links to the Jefferiss Wing at St Mary’s Hospital, a leading UK provider of HIV and sexual health care.
The centre has been researching clinical care for HIV and AIDS for over 30 years. The unit opened in June 1991, with financial support from the Elton John AIDS Foundation and the Jefferiss Trust. Over time, the unit has expanded its remit to undertake research in sexual health, sexual function and infectious diseases. In more recent years, the unit has led several Covid-19 vaccine trials.
The research conducted at the Clinical Trials Centre has been pivotal to improving knowledge around how to care best for people with HIV, with many of these research findings integrated into national guidelines (British HIV Association guidelines).
The centre supports both commercial and non-commercial/academic studies.
Patient and public involvement (PPI) and engagement:
The team at the Clinical Trials Centre are keen to work with the local community to help shape the direction of future research. Patient and Public Involvement and Engagement (PPIE) activities including sharing ideas about future research questions, reviewing and re-shaping study documents before ethics submissions (e.g. study protocols and patient information sheets) and helping share research results with the wider community.
Latest news
-
Read the full storyDraft recommendations on prostate cancer screening issued
Today the UK National Screening Committee – the expert group which advises the government and the NHS on screening – has issued draft recommendations about prostate screening in the UK.
-
Read the full storyFirst men invited to take part in TRANSFORM screening trial - the most ambitious prostate cancer trial in decades
Today, the first men will begin receiving letters from their GPs to join the ambitious £42 million TRANSFORM screening trial - the biggest prostate cancer screening study in a generation.
-
Read the full storyFleming Initiative and GSK unite to target AMR with advanced AI
The Fleming Initiative and GSK have announced six major new research programmes to find new ways to tackle antimicrobial resistance (AMR).